A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Incyte Corporation
Incyte Corporation
Janssen Research & Development, LLC
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Stanford University
Incyte Corporation
iOnctura
OHSU Knight Cancer Institute
Incyte Corporation
Children's Hospital of Philadelphia
City of Hope Medical Center
Case Comprehensive Cancer Center
Mayo Clinic
University of Pennsylvania
University of Chicago
City of Hope Medical Center
University of Chicago
AbbVie
Memorial Sloan Kettering Cancer Center
University of Miami
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
AbbVie
Oncotherapeutics
Vanderbilt-Ingram Cancer Center
OHSU Knight Cancer Institute
Mayo Clinic
Oncotherapeutics
National Cancer Centre, Singapore
AbbVie
University of Michigan Rogel Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
St. Jude Children's Research Hospital
OHSU Knight Cancer Institute
Novartis
Incyte Corporation
Children's Oncology Group